102. Rubinstein-Taybi syndrome Clinical trials / Disease details

Clinical trials : 3 / Drugs : 5 - (DrugBank : 1) / Drug target genes : 7 - Drug target pathways : 17

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01619644 (ClinicalTrials.gov)	April 2012	12/6/2012	Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial	Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial	Rubinstein-Taybi Syndrome	Drug: sodium valproate;Drug: Placebo	University Hospital, Bordeaux	Fondation Syndrome de Rubinstein-Taybi	Completed	6 Years	21 Years	Both	41	Phase 2	France